Return to homepagePandemic Pact

Phase 1 and Phase 2 Clinical Trials for Next-Generation Coronavirus Vaccines

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N91019D00024-P00001-759102300008-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2028

  • Known Financial Commitments (USD)

    $15,048,720

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    KIRAN DATTA

  • Research Location

    United States of America

  • Lead Research Institution

    LEIDOS BIOMEDICAL RESEARCH, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The Objective of this task order supports NIAIDs goal to conduct a series of standardized phase 1 and phase 2 trials on next-generation vaccines to generate data to inform decisions on which candidate to advance.